More in

CytoSorbents launches PuriFi blood pump in the EU

CytoSorbents Corp has launched its PuriFi hemoperfusion machine in the European Union (EU), following approval and certification under the EU Medical Device Regulation (MDR).

CytoSorbents' PuriFi hemoperfusion pump
CytoSorbents' PuriFi hemoperfusion pump

The PuriFi peristaltic blood pump features a pre-assembled adult and pediatric blood line kit, auto-priming, an auto-leveling bubble catcher, an intuitive touchscreen graphical user interface with a step-by-step user-friendly set-up guide, optional blood warming, and a rapid 10-minute set-up time. Together, these unique features enable an easy and rapid way to administer CytoSorbents’ CytoSorb blood purification cartridge for critically ill and cardiac surgery patients.

Vincent Capponi, president and chief operating officer of CytoSorbents, said: “We are excited to launch the PuriFi pump, the result of a 2-year development program with our original equipment manufacturer (OEM) partner, the Medica Group. Innovation is a key growth driver for us and the feature-rich, easy-to-use PuriFi pump exemplifies this.”

Bettina Sabisch, CytoSorbents’ vice president of International Distributor Sales, said: “PuriFi represents a significant advancement in our product portfolio. Its introduction comes at a critical time as the end-user demand for more efficient and effective blood purification solutions is growing in the EU and worldwide.”